Eye Cancer’s Hidden Weakness: CRISPR Screens Expose p300 as a Lifeline for GNAQ-Mutant Tumors
CRISPR-based synthetic lethal screening has identified the acetyltransferases p300 and CBP as essential chromatin partners for YAP-driven transcription in GNAQ-mutant ...

